DrugPatentWatch Database Preview
Details for Biologics License Application: 125431
Try a free trial
See Plans and Pricing
Summary for BLA: 125431
| Tradename: | TANZEUM |
| Applicant: | Glaxosmithkline Llc |
| Ingredient: | albiglutide |
| Patents: | 50 |
| Approval Date: | Apr 15, 2014 |
| Suppliers: see list | 1 |
Pharmacology for BLA: 125431
| Drug Class | GLP-1 Receptor Agonist |
| Mechanism of Action | Glucagon-like Peptide-1 (GLP-1) Agonists |
US Patents for BLA: 125431
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | 2030-05-05 | RX | search | |
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | Rani Therapeutics, LLC (San Jose, CA) | 2030-12-23 | RX | search | |
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | Pfizer Inc. (New York, NY) | 2038-10-17 | RX | search | |
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | Rani Therapeutics, LLC (San Jose, CA) | 2029-12-24 | RX | search | |
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | Rani Therapeutics, LLC (San Jose, CA) | 2029-12-24 | RX | search | |
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY) | 2035-10-12 | RX | search | |
| Glaxosmithkline Llc | TANZEUM | albiglutide | INJECTABLE;INJECTION | 125431 | 001 | 2014-04-15 | ➤ Sign Up | Research Development Foundation (Carson City, NV) | 2034-05-06 | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
